Skip to contentS
SkinHealth Systems Inc.
S
SKINSkinHealth Systems Inc. Q2 2025 · 10-Q
Revenue$78.19M$78.19M−13.7% vs Q2 2024 Net Income$19.71M$19.71M+9,658.4% vs Q2 2024 EPS Diluted$0.03$0.03N/M vs Q2 2024 Gross Profit$49,112,000+20.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SkinHealth Systems Inc. · CIK 1818093 · Engraved from SEC EDGAR
Operating Cash Flowderived$9,646,000+55.6% Free Cash Flowderived$9,554,000+62.8% Margins · derivedGross margin62.8%+17.6 pt vs Q2 2024
Operating margin-3.5%+21.0 pt vs Q2 2024
Net margin25.2%+25.0 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end